Scott Bobbitt

Scott Bobbitt has extensive experience in quality assurance and compliance within the pharmaceutical and biotechnology industry. Scott is currently the Vice President of Quality Assurance at Adicet Bio, Inc, where they are responsible for maintaining and leading the quality organization for cell, gene, and CAR-T manufacturing, testing, and distribution practices.

Prior to their current role, Scott served as the Site Quality Head at Hitachi Chemical Advanced Therapeutics Solutions, LLC, overseeing the quality and compliance of cell and gene therapy manufacturing, testing, and distribution practices. Scott also managed the quality fiscal budget for the site.

Scott has also held positions at Dermira, Inc. as the Senior Director of QA Operations and Novartis as the Associate Director of Quality Assurance Biologics and Global Quality Operations Manager. In these roles, they were responsible for managing quality aspects at contract manufacturing organizations, ensuring compliance with regulatory requirements, and overseeing the completion of various quality projects.

Earlier in their career, Scott held positions at Tiber Laboratories, Genzyme Corporation, Amylin, UCB Pharma, and GlaxoSmithKline, where they gained experience in quality assurance, project management, and leadership.

Overall, Scott Bobbitt has a strong background in quality assurance and compliance, with a focus on the pharmaceutical and biotechnology industry. Scott has extensive experience managing quality organizations, ensuring regulatory compliance, and leading various quality projects.

Scott Bobbitt attended North Carolina Wesleyan University from 1998 to 2000. However, no information is available regarding the degree or field of study they pursued during this time. Later, from 2010 to 2013, they studied at Southern Polytechnic State University, where they obtained a Master's degree in Quality Assurance.